A Double Blind Randomized Crossover Study of Oral Thalidomide versus Placebo in Patients with Stage D0 Androgen Dependent Prostate Cancer Following Limited Hormonal Ablation

BACKGROUND: Androgen deprivation is increasingly being used for the treatment of biochemically recurrent prostate cancer. Thalidomide has been shown to have activity in metastatic prostate cancer. METHODS: 159 patients enrolled in a double-blind randomized trial to determine if thalidomide can impro...

Full description

Saved in:
Bibliographic Details
Main Authors: Figg, William D., Hussain, Maha H., Gulley, James L., Arlen, Philip M., Aragon-Ching, Jeanny B., Petrylak, Daniel P., Higano, Celestia S., Steinberg, Seth M., Sartor, Oliver, Dahut, William L.
Format: Artigo
Language:Inglês
Published: 2009
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2838198/
https://ncbi.nlm.nih.gov/pubmed/19167733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2008.11.026
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items